Essential fatty acid supplementation in chronic hepatitis B

Area of Science:

• Hepatology
• Nutritional Science
• Immunology

Background:

• Dietary supplementation with essential fatty acids and polyunsaturated lecithin may impact liver disease parameters.
• Chronic hepatitis B is a significant global health concern requiring effective treatment strategies.

Purpose of the Study:

• To investigate the efficacy of evening primrose oil, a source of polyunsaturated fatty acids, in treating chronic hepatitis B.
• To evaluate the impact of essential fatty acid supplementation on biochemical and histological markers of liver damage.

Main Methods:

• A randomized controlled trial involving ten patients with chronic hepatitis B.
• Patients received 4 g daily of evening primrose oil or a liquid paraffin placebo for 12 months.
• Biochemical, histological, and serological markers, including e antigen loss, were monitored.

Main Results:

• No significant improvement was observed in biochemical or histological indices of liver damage in the evening primrose oil group compared to placebo.
• The rate of loss of circulating e antigen did not differ between the groups.
• Evening primrose oil supplementation showed no beneficial effect on disease progression markers.

Conclusions:

• Dietary supplementation with essential fatty acids, specifically evening primrose oil at the tested dosage, is unlikely to be beneficial for chronic hepatitis B.
• Further research may be needed to explore other fatty acid formulations or dosages, but current evidence is negative.
• This study advises against using evening primrose oil for managing chronic hepatitis B based on the observed outcomes.